世界のメサラミン（リアルダ）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Mesalamine (Lialda) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3709 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、メサラミン（リアルダ）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（浣腸、錠剤、座薬、その他）、用途別市場規模（大腸炎、クローン病、直腸炎、下痢性過敏性腸症候群、憩室炎、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・メサラミン（リアルダ）の市場動向 ・企業の競争状況、市場シェア ・メサラミン（リアルダ）の種類別市場規模（浣腸、錠剤、座薬、その他） ・メサラミン（リアルダ）の用途別市場規模（大腸炎、クローン病、直腸炎、下痢性過敏性腸症候群、憩室炎、その他） ・メサラミン（リアルダ）の北米市場規模2016-2027（アメリカ、カナダ） ・メサラミン（リアルダ）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・メサラミン（リアルダ）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・メサラミン（リアルダ）の中南米市場規模2016-2027（メキシコ、ブラジル） ・メサラミン（リアルダ）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Dr.Falk Pharma、Ferring、Ethypharm Pharmaceutical、Shanghai Pharmaceutical、Tillotts Pharma、Holy Stone Healthcare、Giuliani、Zeria、Lupin、Heilongjiang Tianhong Pharmaceutical、HENGCHENG PHARMACEUTICAL、KWAI FA Pharmaceutical Group） ・結論

An anti-inflammatory agent, structurally related to the salicylates and non-steroidal anti-inflammatory drugs like acetylsalicylic acid, which is active in inflammatory bowel disease 2. It is considered to be the active moiety of sulphasalazine. (From Martindale, The Extra Pharmacopoeia, 30th ed) Although demonstrably effective in treating and maintaining remission for ulcerative colitis, mesalazine has historically faced a number of issues regarding its lack of stability as a pharmaceutical agent.

Market Analysis and Insights: Global Mesalamine (Lialda) Market
The global Mesalamine (Lialda) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mesalamine (Lialda) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mesalamine (Lialda) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mesalamine (Lialda) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mesalamine (Lialda) market.

Global Mesalamine (Lialda) Scope and Market Size
Mesalamine (Lialda) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mesalamine (Lialda) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Enemas
Tablets
Suppositories
Other

Segment by Application
Colitis
Crohn’s Disease
Proctitis
Diarrheal Irritable Bowel Syndrome
Diverticulitis
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Dr.Falk Pharma
Ferring
Ethypharm Pharmaceutical
Shanghai Pharmaceutical
Tillotts Pharma
Holy Stone Healthcare
Giuliani
Zeria
Lupin
Heilongjiang Tianhong Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mesalamine (Lialda) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Enemas
1.2.3 Tablets
1.2.4 Suppositories
1.2.5 Other
1.3 Market by Application
1.3.1 Global Mesalamine (Lialda) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Colitis
1.3.3 Crohn’s Disease
1.3.4 Proctitis
1.3.5 Diarrheal Irritable Bowel Syndrome
1.3.6 Diverticulitis
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Mesalamine (Lialda) Market Perspective (2016-2027)
2.2 Mesalamine (Lialda) Growth Trends by Regions
2.2.1 Mesalamine (Lialda) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mesalamine (Lialda) Historic Market Share by Regions (2016-2021)
2.2.3 Mesalamine (Lialda) Forecasted Market Size by Regions (2022-2027)
2.3 Mesalamine (Lialda) Industry Dynamic
2.3.1 Mesalamine (Lialda) Market Trends
2.3.2 Mesalamine (Lialda) Market Drivers
2.3.3 Mesalamine (Lialda) Market Challenges
2.3.4 Mesalamine (Lialda) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Mesalamine (Lialda) Players by Revenue
3.1.1 Global Top Mesalamine (Lialda) Players by Revenue (2016-2021)
3.1.2 Global Mesalamine (Lialda) Revenue Market Share by Players (2016-2021)
3.2 Global Mesalamine (Lialda) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mesalamine (Lialda) Revenue
3.4 Global Mesalamine (Lialda) Market Concentration Ratio
3.4.1 Global Mesalamine (Lialda) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mesalamine (Lialda) Revenue in 2020
3.5 Mesalamine (Lialda) Key Players Head office and Area Served
3.6 Key Players Mesalamine (Lialda) Product Solution and Service
3.7 Date of Enter into Mesalamine (Lialda) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Mesalamine (Lialda) Breakdown Data by Type
4.1 Global Mesalamine (Lialda) Historic Market Size by Type (2016-2021)
4.2 Global Mesalamine (Lialda) Forecasted Market Size by Type (2022-2027)

5 Mesalamine (Lialda) Breakdown Data by Application
5.1 Global Mesalamine (Lialda) Historic Market Size by Application (2016-2021)
5.2 Global Mesalamine (Lialda) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Mesalamine (Lialda) Market Size (2016-2027)
6.2 North America Mesalamine (Lialda) Market Size by Type
6.2.1 North America Mesalamine (Lialda) Market Size by Type (2016-2021)
6.2.2 North America Mesalamine (Lialda) Market Size by Type (2022-2027)
6.2.3 North America Mesalamine (Lialda) Market Size by Type (2016-2027)
6.3 North America Mesalamine (Lialda) Market Size by Application
6.3.1 North America Mesalamine (Lialda) Market Size by Application (2016-2021)
6.3.2 North America Mesalamine (Lialda) Market Size by Application (2022-2027)
6.3.3 North America Mesalamine (Lialda) Market Size by Application (2016-2027)
6.4 North America Mesalamine (Lialda) Market Size by Country
6.4.1 North America Mesalamine (Lialda) Market Size by Country (2016-2021)
6.4.2 North America Mesalamine (Lialda) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Mesalamine (Lialda) Market Size (2016-2027)
7.2 Europe Mesalamine (Lialda) Market Size by Type
7.2.1 Europe Mesalamine (Lialda) Market Size by Type (2016-2021)
7.2.2 Europe Mesalamine (Lialda) Market Size by Type (2022-2027)
7.2.3 Europe Mesalamine (Lialda) Market Size by Type (2016-2027)
7.3 Europe Mesalamine (Lialda) Market Size by Application
7.3.1 Europe Mesalamine (Lialda) Market Size by Application (2016-2021)
7.3.2 Europe Mesalamine (Lialda) Market Size by Application (2022-2027)
7.3.3 Europe Mesalamine (Lialda) Market Size by Application (2016-2027)
7.4 Europe Mesalamine (Lialda) Market Size by Country
7.4.1 Europe Mesalamine (Lialda) Market Size by Country (2016-2021)
7.4.2 Europe Mesalamine (Lialda) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Mesalamine (Lialda) Market Size (2016-2027)
8.2 Asia-Pacific Mesalamine (Lialda) Market Size by Type
8.2.1 Asia-Pacific Mesalamine (Lialda) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mesalamine (Lialda) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mesalamine (Lialda) Market Size by Type (2016-2027)
8.3 Asia-Pacific Mesalamine (Lialda) Market Size by Application
8.3.1 Asia-Pacific Mesalamine (Lialda) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mesalamine (Lialda) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mesalamine (Lialda) Market Size by Application (2016-2027)
8.4 Asia-Pacific Mesalamine (Lialda) Market Size by Region
8.4.1 Asia-Pacific Mesalamine (Lialda) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mesalamine (Lialda) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Mesalamine (Lialda) Market Size (2016-2027)
9.2 Latin America Mesalamine (Lialda) Market Size by Type
9.2.1 Latin America Mesalamine (Lialda) Market Size by Type (2016-2021)
9.2.2 Latin America Mesalamine (Lialda) Market Size by Type (2022-2027)
9.2.3 Latin America Mesalamine (Lialda) Market Size by Type (2016-2027)
9.3 Latin America Mesalamine (Lialda) Market Size by Application
9.3.1 Latin America Mesalamine (Lialda) Market Size by Application (2016-2021)
9.3.2 Latin America Mesalamine (Lialda) Market Size by Application (2022-2027)
9.3.3 Latin America Mesalamine (Lialda) Market Size by Application (2016-2027)
9.4 Latin America Mesalamine (Lialda) Market Size by Country
9.4.1 Latin America Mesalamine (Lialda) Market Size by Country (2016-2021)
9.4.2 Latin America Mesalamine (Lialda) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Mesalamine (Lialda) Market Size (2016-2027)
10.2 Middle East & Africa Mesalamine (Lialda) Market Size by Type
10.2.1 Middle East & Africa Mesalamine (Lialda) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mesalamine (Lialda) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mesalamine (Lialda) Market Size by Type (2016-2027)
10.3 Middle East & Africa Mesalamine (Lialda) Market Size by Application
10.3.1 Middle East & Africa Mesalamine (Lialda) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mesalamine (Lialda) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mesalamine (Lialda) Market Size by Application (2016-2027)
10.4 Middle East & Africa Mesalamine (Lialda) Market Size by Country
10.4.1 Middle East & Africa Mesalamine (Lialda) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mesalamine (Lialda) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Dr.Falk Pharma
11.1.1 Dr.Falk Pharma Company Details
11.1.2 Dr.Falk Pharma Business Overview
11.1.3 Dr.Falk Pharma Mesalamine (Lialda) Introduction
11.1.4 Dr.Falk Pharma Revenue in Mesalamine (Lialda) Business (2016-2021)
11.1.5 Dr.Falk Pharma Recent Development
11.2 Ferring
11.2.1 Ferring Company Details
11.2.2 Ferring Business Overview
11.2.3 Ferring Mesalamine (Lialda) Introduction
11.2.4 Ferring Revenue in Mesalamine (Lialda) Business (2016-2021)
11.2.5 Ferring Recent Development
11.3 Ethypharm Pharmaceutical
11.3.1 Ethypharm Pharmaceutical Company Details
11.3.2 Ethypharm Pharmaceutical Business Overview
11.3.3 Ethypharm Pharmaceutical Mesalamine (Lialda) Introduction
11.3.4 Ethypharm Pharmaceutical Revenue in Mesalamine (Lialda) Business (2016-2021)
11.3.5 Ethypharm Pharmaceutical Recent Development
11.4 Shanghai Pharmaceutical
11.4.1 Shanghai Pharmaceutical Company Details
11.4.2 Shanghai Pharmaceutical Business Overview
11.4.3 Shanghai Pharmaceutical Mesalamine (Lialda) Introduction
11.4.4 Shanghai Pharmaceutical Revenue in Mesalamine (Lialda) Business (2016-2021)
11.4.5 Shanghai Pharmaceutical Recent Development
11.5 Tillotts Pharma
11.5.1 Tillotts Pharma Company Details
11.5.2 Tillotts Pharma Business Overview
11.5.3 Tillotts Pharma Mesalamine (Lialda) Introduction
11.5.4 Tillotts Pharma Revenue in Mesalamine (Lialda) Business (2016-2021)
11.5.5 Tillotts Pharma Recent Development
11.6 Holy Stone Healthcare
11.6.1 Holy Stone Healthcare Company Details
11.6.2 Holy Stone Healthcare Business Overview
11.6.3 Holy Stone Healthcare Mesalamine (Lialda) Introduction
11.6.4 Holy Stone Healthcare Revenue in Mesalamine (Lialda) Business (2016-2021)
11.6.5 Holy Stone Healthcare Recent Development
11.7 Giuliani
11.7.1 Giuliani Company Details
11.7.2 Giuliani Business Overview
11.7.3 Giuliani Mesalamine (Lialda) Introduction
11.7.4 Giuliani Revenue in Mesalamine (Lialda) Business (2016-2021)
11.7.5 Giuliani Recent Development
11.8 Zeria
11.8.1 Zeria Company Details
11.8.2 Zeria Business Overview
11.8.3 Zeria Mesalamine (Lialda) Introduction
11.8.4 Zeria Revenue in Mesalamine (Lialda) Business (2016-2021)
11.8.5 Zeria Recent Development
11.9 Lupin
11.9.1 Lupin Company Details
11.9.2 Lupin Business Overview
11.9.3 Lupin Mesalamine (Lialda) Introduction
11.9.4 Lupin Revenue in Mesalamine (Lialda) Business (2016-2021)
11.9.5 Lupin Recent Development
11.10 Heilongjiang Tianhong Pharmaceutical
11.10.1 Heilongjiang Tianhong Pharmaceutical Company Details
11.10.2 Heilongjiang Tianhong Pharmaceutical Business Overview
11.10.3 Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Introduction
11.10.4 Heilongjiang Tianhong Pharmaceutical Revenue in Mesalamine (Lialda) Business (2016-2021)
11.10.5 Heilongjiang Tianhong Pharmaceutical Recent Development
11.11 HENGCHENG PHARMACEUTICAL
11.11.1 HENGCHENG PHARMACEUTICAL Company Details
11.11.2 HENGCHENG PHARMACEUTICAL Business Overview
11.11.3 HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Introduction
11.11.4 HENGCHENG PHARMACEUTICAL Revenue in Mesalamine (Lialda) Business (2016-2021)
11.11.5 HENGCHENG PHARMACEUTICAL Recent Development
11.12 KWAI FA Pharmaceutical Group
11.12.1 KWAI FA Pharmaceutical Group Company Details
11.12.2 KWAI FA Pharmaceutical Group Business Overview
11.12.3 KWAI FA Pharmaceutical Group Mesalamine (Lialda) Introduction
11.12.4 KWAI FA Pharmaceutical Group Revenue in Mesalamine (Lialda) Business (2016-2021)
11.12.5 KWAI FA Pharmaceutical Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Mesalamine (Lialda) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Enemas
Table 3. Key Players of Tablets
Table 4. Key Players of Suppositories
Table 5. Key Players of Other
Table 6. Global Mesalamine (Lialda) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Mesalamine (Lialda) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Mesalamine (Lialda) Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Mesalamine (Lialda) Market Share by Regions (2016-2021)
Table 10. Global Mesalamine (Lialda) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Mesalamine (Lialda) Market Share by Regions (2022-2027)
Table 12. Mesalamine (Lialda) Market Trends
Table 13. Mesalamine (Lialda) Market Drivers
Table 14. Mesalamine (Lialda) Market Challenges
Table 15. Mesalamine (Lialda) Market Restraints
Table 16. Global Mesalamine (Lialda) Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Mesalamine (Lialda) Market Share by Players (2016-2021)
Table 18. Global Top Mesalamine (Lialda) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine (Lialda) as of 2020)
Table 19. Ranking of Global Top Mesalamine (Lialda) Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Mesalamine (Lialda) Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Mesalamine (Lialda) Product Solution and Service
Table 23. Date of Enter into Mesalamine (Lialda) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mesalamine (Lialda) Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Mesalamine (Lialda) Revenue Market Share by Type (2016-2021)
Table 27. Global Mesalamine (Lialda) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Mesalamine (Lialda) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Mesalamine (Lialda) Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Mesalamine (Lialda) Revenue Market Share by Application (2016-2021)
Table 31. Global Mesalamine (Lialda) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Mesalamine (Lialda) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Mesalamine (Lialda) Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Mesalamine (Lialda) Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Mesalamine (Lialda) Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Mesalamine (Lialda) Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Mesalamine (Lialda) Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Mesalamine (Lialda) Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Mesalamine (Lialda) Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Mesalamine (Lialda) Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Mesalamine (Lialda) Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Mesalamine (Lialda) Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Mesalamine (Lialda) Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Mesalamine (Lialda) Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Mesalamine (Lialda) Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Mesalamine (Lialda) Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Mesalamine (Lialda) Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Mesalamine (Lialda) Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Mesalamine (Lialda) Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Mesalamine (Lialda) Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Mesalamine (Lialda) Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Mesalamine (Lialda) Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Mesalamine (Lialda) Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Mesalamine (Lialda) Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Mesalamine (Lialda) Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Mesalamine (Lialda) Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Mesalamine (Lialda) Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Mesalamine (Lialda) Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Mesalamine (Lialda) Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Mesalamine (Lialda) Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Mesalamine (Lialda) Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Mesalamine (Lialda) Market Size by Country (2022-2027) & (US$ Million)
Table 63. Dr.Falk Pharma Company Details
Table 64. Dr.Falk Pharma Business Overview
Table 65. Dr.Falk Pharma Mesalamine (Lialda) Product
Table 66. Dr.Falk Pharma Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 67. Dr.Falk Pharma Recent Development
Table 68. Ferring Company Details
Table 69. Ferring Business Overview
Table 70. Ferring Mesalamine (Lialda) Product
Table 71. Ferring Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 72. Ferring Recent Development
Table 73. Ethypharm Pharmaceutical Company Details
Table 74. Ethypharm Pharmaceutical Business Overview
Table 75. Ethypharm Pharmaceutical Mesalamine (Lialda) Product
Table 76. Ethypharm Pharmaceutical Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 77. Ethypharm Pharmaceutical Recent Development
Table 78. Shanghai Pharmaceutical Company Details
Table 79. Shanghai Pharmaceutical Business Overview
Table 80. Shanghai Pharmaceutical Mesalamine (Lialda) Product
Table 81. Shanghai Pharmaceutical Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 82. Shanghai Pharmaceutical Recent Development
Table 83. Tillotts Pharma Company Details
Table 84. Tillotts Pharma Business Overview
Table 85. Tillotts Pharma Mesalamine (Lialda) Product
Table 86. Tillotts Pharma Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 87. Tillotts Pharma Recent Development
Table 88. Holy Stone Healthcare Company Details
Table 89. Holy Stone Healthcare Business Overview
Table 90. Holy Stone Healthcare Mesalamine (Lialda) Product
Table 91. Holy Stone Healthcare Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 92. Holy Stone Healthcare Recent Development
Table 93. Giuliani Company Details
Table 94. Giuliani Business Overview
Table 95. Giuliani Mesalamine (Lialda) Product
Table 96. Giuliani Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 97. Giuliani Recent Development
Table 98. Zeria Company Details
Table 99. Zeria Business Overview
Table 100. Zeria Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 101. Zeria Recent Development
Table 102. Lupin Company Details
Table 103. Lupin Business Overview
Table 104. Lupin Mesalamine (Lialda) Product
Table 105. Lupin Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 106. Lupin Recent Development
Table 107. Heilongjiang Tianhong Pharmaceutical Company Details
Table 108. Heilongjiang Tianhong Pharmaceutical Business Overview
Table 109. Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Product
Table 110. Heilongjiang Tianhong Pharmaceutical Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 111. Heilongjiang Tianhong Pharmaceutical Recent Development
Table 112. HENGCHENG PHARMACEUTICAL Company Details
Table 113. HENGCHENG PHARMACEUTICAL Business Overview
Table 114. HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Product
Table 115. HENGCHENG PHARMACEUTICAL Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 116. HENGCHENG PHARMACEUTICAL Recent Development
Table 117. KWAI FA Pharmaceutical Group Company Details
Table 118. KWAI FA Pharmaceutical Group Business Overview
Table 119. KWAI FA Pharmaceutical Group Mesalamine (Lialda) Product
Table 120. KWAI FA Pharmaceutical Group Revenue in Mesalamine (Lialda) Business (2016-2021) & (US$ Million)
Table 121. KWAI FA Pharmaceutical Group Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mesalamine (Lialda) Market Share by Type: 2020 VS 2027
Figure 2. Enemas Features
Figure 3. Tablets Features
Figure 4. Suppositories Features
Figure 5. Other Features
Figure 6. Global Mesalamine (Lialda) Market Share by Application: 2020 VS 2027
Figure 7. Colitis Case Studies
Figure 8. Crohn's Disease Case Studies
Figure 9. Proctitis Case Studies
Figure 10. Diarrheal Irritable Bowel Syndrome Case Studies
Figure 11. Diverticulitis Case Studies
Figure 12. Other Case Studies
Figure 13. Mesalamine (Lialda) Report Years Considered
Figure 14. Global Mesalamine (Lialda) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Mesalamine (Lialda) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Mesalamine (Lialda) Market Share by Regions: 2020 VS 2027
Figure 17. Global Mesalamine (Lialda) Market Share by Regions (2022-2027)
Figure 18. Global Mesalamine (Lialda) Market Share by Players in 2020
Figure 19. Global Top Mesalamine (Lialda) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalamine (Lialda) as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Mesalamine (Lialda) Revenue in 2020
Figure 21. Global Mesalamine (Lialda) Revenue Market Share by Type (2016-2021)
Figure 22. Global Mesalamine (Lialda) Revenue Market Share by Type (2022-2027)
Figure 23. North America Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Mesalamine (Lialda) Market Share by Type (2016-2027)
Figure 25. North America Mesalamine (Lialda) Market Share by Application (2016-2027)
Figure 26. North America Mesalamine (Lialda) Market Share by Country (2016-2027)
Figure 27. United States Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Mesalamine (Lialda) Market Share by Type (2016-2027)
Figure 31. Europe Mesalamine (Lialda) Market Share by Application (2016-2027)
Figure 32. Europe Mesalamine (Lialda) Market Share by Country (2016-2027)
Figure 33. Germany Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Mesalamine (Lialda) Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Mesalamine (Lialda) Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Mesalamine (Lialda) Market Share by Region (2016-2027)
Figure 43. China Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Mesalamine (Lialda) Market Share by Type (2016-2027)
Figure 51. Latin America Mesalamine (Lialda) Market Share by Application (2016-2027)
Figure 52. Latin America Mesalamine (Lialda) Market Share by Country (2016-2027)
Figure 53. Mexico Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Mesalamine (Lialda) Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Mesalamine (Lialda) Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Mesalamine (Lialda) Market Share by Country (2016-2027)
Figure 59. Turkey Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Mesalamine (Lialda) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Dr.Falk Pharma Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 63. Ferring Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 64. Ethypharm Pharmaceutical Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 65. Shanghai Pharmaceutical Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 66. Tillotts Pharma Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 67. Holy Stone Healthcare Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 68. Giuliani Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 69. Zeria Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 70. Lupin Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 71. Heilongjiang Tianhong Pharmaceutical Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 72. HENGCHENG PHARMACEUTICAL Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 73. KWAI FA Pharmaceutical Group Revenue Growth Rate in Mesalamine (Lialda) Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---